Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Crinetics Pharmaceuticals, Inc. Director's Dealing 2021

Sep 2, 2021

31156_dirs_2021-09-02_fc4a5137-3858-4dc0-ac91-8f90a77e9214.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Crinetics Pharmaceuticals, Inc. (CRNX)
CIK: 0001658247
Period of Report: 2021-08-30

Reporting Person: Knight Jeff E. (Chief Operating Officer)

More from Crinetics Pharmaceuticals, Inc.

Board/Management Information 2026
Mar 23
Director's Dealing 2026
Mar 4
Director's Dealing 2026
Mar 4
Audit Report / Information 2026
Mar 3
Annual Report 2026
Feb 26
Regulatory Filings 2026
Feb 26
Director's Dealing 2026
Feb 25
Director's Dealing 2026
Feb 25
Director's Dealing 2026
Feb 25
Director's Dealing 2026
Feb 25
View all filings →